Cargando…
Applications of machine learning in decision analysis for dose management for dofetilide
BACKGROUND: Initiation of the antiarrhythmic medication dofetilide requires an FDA-mandated 3 days of telemetry monitoring due to heightened risk of toxicity within this time period. Although a recommended dose management algorithm for dofetilide exists, there is a range of real-world approaches to...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938356/ https://www.ncbi.nlm.nih.gov/pubmed/31891645 http://dx.doi.org/10.1371/journal.pone.0227324 |
_version_ | 1783484023523246080 |
---|---|
author | Levy, Andrew E. Biswas, Minakshi Weber, Rachel Tarakji, Khaldoun Chung, Mina Noseworthy, Peter A. Newton-Cheh, Christopher Rosenberg, Michael A. |
author_facet | Levy, Andrew E. Biswas, Minakshi Weber, Rachel Tarakji, Khaldoun Chung, Mina Noseworthy, Peter A. Newton-Cheh, Christopher Rosenberg, Michael A. |
author_sort | Levy, Andrew E. |
collection | PubMed |
description | BACKGROUND: Initiation of the antiarrhythmic medication dofetilide requires an FDA-mandated 3 days of telemetry monitoring due to heightened risk of toxicity within this time period. Although a recommended dose management algorithm for dofetilide exists, there is a range of real-world approaches to dosing the medication. METHODS AND RESULTS: In this multicenter investigation, clinical data from the Antiarrhythmic Drug Genetic (AADGEN) study was examined for 354 patients undergoing dofetilide initiation. Univariate logistic regression identified a starting dofetilide dose of 500 mcg (OR 5.0, 95%CI 2.5–10.0, p<0.001) and sinus rhythm at the start of dofetilide loading (OR 2.8, 95%CI 1.8–4.2, p<0.001) as strong positive predictors of successful loading. Any dose-adjustment during loading (OR 0.19, 95%CI 0.12–0.31, p<0.001) and a history coronary artery disease (OR 0.33, 95%CI 0.19–0.59, p<0.001) were strong negative predictors of successful dofetilide loading. Based on the observation that any dose adjustment was a significant negative predictor of successful initiation, we applied multiple supervised approaches to attempt to predict the dose adjustment decision, but none of these approaches identified dose adjustments better than a probabilistic guess. Principal component analysis and cluster analysis identified 8 clusters as a reasonable data reduction method. These 8 clusters were then used to define patient states in a tabular reinforcement learning model trained on 80% of dosing decisions. Testing of this model on the remaining 20% of dosing decisions revealed good accuracy of the reinforcement learning model, with only 16/410 (3.9%) instances of disagreement. CONCLUSIONS: Dose adjustments are a strong determinant of whether patients are able to successfully initiate dofetilide. A reinforcement learning algorithm informed by unsupervised learning was able to predict dosing decisions with 96.1% accuracy. Future studies will apply this algorithm prospectively as a data-driven decision aid. |
format | Online Article Text |
id | pubmed-6938356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-69383562020-01-07 Applications of machine learning in decision analysis for dose management for dofetilide Levy, Andrew E. Biswas, Minakshi Weber, Rachel Tarakji, Khaldoun Chung, Mina Noseworthy, Peter A. Newton-Cheh, Christopher Rosenberg, Michael A. PLoS One Research Article BACKGROUND: Initiation of the antiarrhythmic medication dofetilide requires an FDA-mandated 3 days of telemetry monitoring due to heightened risk of toxicity within this time period. Although a recommended dose management algorithm for dofetilide exists, there is a range of real-world approaches to dosing the medication. METHODS AND RESULTS: In this multicenter investigation, clinical data from the Antiarrhythmic Drug Genetic (AADGEN) study was examined for 354 patients undergoing dofetilide initiation. Univariate logistic regression identified a starting dofetilide dose of 500 mcg (OR 5.0, 95%CI 2.5–10.0, p<0.001) and sinus rhythm at the start of dofetilide loading (OR 2.8, 95%CI 1.8–4.2, p<0.001) as strong positive predictors of successful loading. Any dose-adjustment during loading (OR 0.19, 95%CI 0.12–0.31, p<0.001) and a history coronary artery disease (OR 0.33, 95%CI 0.19–0.59, p<0.001) were strong negative predictors of successful dofetilide loading. Based on the observation that any dose adjustment was a significant negative predictor of successful initiation, we applied multiple supervised approaches to attempt to predict the dose adjustment decision, but none of these approaches identified dose adjustments better than a probabilistic guess. Principal component analysis and cluster analysis identified 8 clusters as a reasonable data reduction method. These 8 clusters were then used to define patient states in a tabular reinforcement learning model trained on 80% of dosing decisions. Testing of this model on the remaining 20% of dosing decisions revealed good accuracy of the reinforcement learning model, with only 16/410 (3.9%) instances of disagreement. CONCLUSIONS: Dose adjustments are a strong determinant of whether patients are able to successfully initiate dofetilide. A reinforcement learning algorithm informed by unsupervised learning was able to predict dosing decisions with 96.1% accuracy. Future studies will apply this algorithm prospectively as a data-driven decision aid. Public Library of Science 2019-12-31 /pmc/articles/PMC6938356/ /pubmed/31891645 http://dx.doi.org/10.1371/journal.pone.0227324 Text en © 2019 Levy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Levy, Andrew E. Biswas, Minakshi Weber, Rachel Tarakji, Khaldoun Chung, Mina Noseworthy, Peter A. Newton-Cheh, Christopher Rosenberg, Michael A. Applications of machine learning in decision analysis for dose management for dofetilide |
title | Applications of machine learning in decision analysis for dose management for dofetilide |
title_full | Applications of machine learning in decision analysis for dose management for dofetilide |
title_fullStr | Applications of machine learning in decision analysis for dose management for dofetilide |
title_full_unstemmed | Applications of machine learning in decision analysis for dose management for dofetilide |
title_short | Applications of machine learning in decision analysis for dose management for dofetilide |
title_sort | applications of machine learning in decision analysis for dose management for dofetilide |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6938356/ https://www.ncbi.nlm.nih.gov/pubmed/31891645 http://dx.doi.org/10.1371/journal.pone.0227324 |
work_keys_str_mv | AT levyandrewe applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide AT biswasminakshi applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide AT weberrachel applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide AT tarakjikhaldoun applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide AT chungmina applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide AT noseworthypetera applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide AT newtonchehchristopher applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide AT rosenbergmichaela applicationsofmachinelearningindecisionanalysisfordosemanagementfordofetilide |